SWEDISH ORPHAN BIOVITRUM AB 08/05/2025 AGM
1Opening of the MeetingNon-Voting
2Election of the chair of the MeetingFor
3Preparation and approval of the voting listFor
4Approval of the agendaFor
5Designate Inspector(s) of Minutes of Meeting Non-Voting
6Acknowledge Proper Convening of Meeting For
7Receive Financial Statement and Statutory ReportsNon-Voting
8Receive President's ReportNon-Voting
9Receive Report on Work of Board and CommitteesNon-Voting
10Approve Financial StatementsFor
11Approve the DividendFor
12.1Discharge the Board: Christophe Bourdon For
12.2Discharge the Board: Annette Clancy For
12.3Discharge the Board: Bo Jesper Hansen For
12.4Discharge the Board: David Meek For
12.5Discharge the Board: Zlatko Rihter For
12.6Discharge the Board: Helena SaxonFor
12.7Discharge the Board: Staffan Schuberg For
12.8Discharge the Board: Filippa Stenberg For
12.9Discharge the Board: Anders Ullman For
12.10Discharge the Board: Mats Lek For
12.11Discharge the Board: Katy Mazibuko For
12.12Discharge the Board: Sara Carlsson For
12.13Discharge the Board: Asa Kjellstrom For
12.14Discharge the Board: Susanna Ronnback For
12.15Discharge the Board: Guido Oelkers (CEO)For
13.1Approve Fees Payable to the Board of DirectorsOppose
13.2Allow the Board to Determine the Auditor's RemunerationFor
14.1Set the Number of Board DirectorsFor
14.2Set the Number of AuditorsFor
15.aRe-elect Christophe Bourdon - Non-Executive DirectorFor
15.bRe-elect David Meek - Non-Executive DirectorOppose
15.cRe-elect Zlatko Rihter - Non-Executive DirectorFor
15.dRe-elect Helena Saxon - Non-Executive DirectorOppose
15.eRe-elect Staffan Schüberg - Non-Executive DirectorFor
15.fRe-elect Filippa Stenberg - Non-Executive DirectorOppose
15.gRe-elect Anders Ullman - Non-Executive DirectorFor
15.hElect Iris Loew-Friedrich - Non-Executive DirectorFor
15.iElect David Meek as Board ChairOppose
15.jAppoint the AuditorsOppose
16Approve the Remuneration ReportOppose
17A1Approve New Long Term Incentive Plan (Management Programme)Oppose
17A2Approve Equity Plan Financing (All Employee Program)Oppose
17B1Authorise Share Repurchase (Management Programme)For
17B2Authorise Share Repurchase (All Employee Programme)For
17.CEquity Swap Agreement with a Third PartyFor
18Issue BondsFor
19Approve Transfer of Shares in Connection with Previous Share ProgramsFor
20Closing of the MeetingNon-Voting